XENE CIK: 1582313

Xenon Pharmaceuticals Inc.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.56
FY22:
0.60
FY23:
0.64
FY24:
0.64
FY25:
0.56
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.15
FY23:
0.32
FY24:
0.16
FY25:
0.07
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.57
FY22:
0.75
FY23:
0.96
FY24:
0.80
FY25:
0.63

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.02
FY23:
0.03
FY24:
0.04
FY25:
0.04
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.01
FY23:
0.01
FY24:
0.01
FY25:
0.01
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.55
FY22:
0.72
FY23:
0.93
FY24:
0.75
FY25:
0.58
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.57
FY22:
0.75
FY23:
0.96
FY24:
0.80
FY25:
0.63

All amounts in billions USD Data source:SEC EDGAR